Dr Ralf Reski on Moss-Made Biopharmaceuticals: aHUS Alliance Interview
The aHUS Alliance recently conducted an interview with Dr Ralf Reski, a professor and researcher in the field of…
The aHUS Alliance recently conducted an interview with Dr Ralf Reski, a professor and researcher in the field of…
It was little known, but Alexion decided years ago that it would reinvest 40% of any of its profits from the…
The Last in the aHUS Alliance Four Part Series Patients Included: Reality or Unmet Goal? 4 MYTHS of Rare…
Following aHUS India's response came two replies from The Netherlands and UK in Europe. Their expectations reflect a very different position…
The SECOND Article in a Four Part Series Rare Disease Advocacy: Digging deeper into Common Misperceptions Although there…
Rare Disease Day will be marked around the world on 28 February 2018 and the aHUS Alliance is pleased to announce…
It can be a struggle to find information about medical conditions if you’ve been diagnosed with a rare disease, and…
The aHUS Alliance is pleased to spotlight aHUS Romania (SHUa Romania) in this interview with Dr. Adrian Lungu, a…
Thrombotic Microangiopathy Symposium: Through the Lens of aHUS 24 August 2017 in Boston Post-Event Update: LIVE BLOG: At…